Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
*Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials..
*Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials..
*HONG KONG, May 28, 2024 - (ACN Newswire) -* Fosun International (HKEX: 0656) issued an announcement on 28 May 2024, announcing..
Experts' Tips on Taking, Supplements as Sleep-Aids.
'Time' recently spoke with experts regarding
over-the-counter sleep..